CC Small or few human trials. Promising, not proven. How we grade →Meta-analysis · 27 trials, 2,569 people
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
J Lan, Y Zhao, F Dong, et al. Journal of Ethnopharmacology. 2015.
- In plain language
- Berberine plus lifestyle change beat lifestyle alone on glucose, HbA1c and cholesterol; there was no significant difference versus standard glucose-lowering pills; no serious adverse reactions were reported.
- Limits
- Included trials were of limited quality, as the authors noted; most were Chinese.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Berberine and glucose metabolism
- CC Small or few human trials. Promising, not proven. How we grade →Ratings card: Berberine HCl: Healthy glucose metabolism
- Source
- doi.org/10.1016/j.jep.2014.09.049 · PubMed 25498346
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.